Ignite Creation Date:
2024-05-05 @ 12:09 PM
Last Modification Date:
2024-10-26 @ 9:21 AM
Study NCT ID:
NCT00267683
Status:
TERMINATED
Last Update Posted:
2023-11-02
First Post:
2005-12-20
Brief Title:
Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Sponsor:
Organization:
Novo Nordisk AS